Literature DB >> 3032102

Protease-deficient Bacillus subtilis host strains for production of Staphylococcal protein A.

S R Fahnestock, K E Fisher.   

Abstract

We constructed strains of Bacillus subtilis which produced very low levels of extracellular proteases. These strains carried insertion or deletion mutations in the subtilisin structural gene (apr) which were constructed in vitro by using the cloned gene. The methods used to construct the mutations involved the use of a plasmid vector which allowed the selection of chromosomal integrates and their subsequent excision by homologous recombination to effect replacement of the chromosomal apr gene by a derivative carrying an inactivating insert with a selectable marker (a cat gene conferring chloramphenicol resistance). The strains produced no subtilisin, no detectable extracellular metalloprotease activity, and residual extracellular serine protease levels as low as 0.5% of that of the standard strain from which they were derived. The strains proved to be superior host strains for the production of staphylococcal protein A, accumulating higher levels of intact protein than do previously available B. subtilis strains.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032102      PMCID: PMC203669          DOI: 10.1128/aem.53.2.379-384.1987

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  19 in total

1.  Expression of the staphylococcal protein A gene in Bacillus subtilis by gene fusions utilizing the promoter from a Bacillus amyloliquefaciens alpha-amylase gene.

Authors:  S R Fahnestock; K E Fisher
Journal:  J Bacteriol       Date:  1986-03       Impact factor: 3.490

2.  Replacement of chromosome segments with altered DNA sequences constructed in vitro.

Authors:  S Scherer; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

3.  Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibodies.

Authors:  S Horinouchi; B Weisblum
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

4.  A dot-immunobinding assay for monoclonal and other antibodies.

Authors:  R Hawkes; E Niday; J Gordon
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

5.  Physiological studies on early-blocked sporulation mutants of Bacillus subtilis.

Authors:  J F Michel; J Millet
Journal:  J Appl Bacteriol       Date:  1970-03

6.  Thermosensitive, extracellular neutral proteases in Bacillus subtilis: isolation, characterization, and genetics.

Authors:  H Uehara; K Yamane; B Maruo
Journal:  J Bacteriol       Date:  1979-08       Impact factor: 3.490

7.  Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance.

Authors:  S Horinouchi; B Weisblum
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

8.  Mapping a cloned gene under sporulation control by inserttion of a drug resistance marker into the Bacillus subtilis chromosome.

Authors:  W G Haldenwang; C D Banner; J F Ollington; R Losick; J A Hoch; M B O'Connor; A L Sonenshein
Journal:  J Bacteriol       Date:  1980-04       Impact factor: 3.490

9.  Gene for staphylococcal protein A.

Authors:  S Löfdahl; B Guss; M Uhlén; L Philipson; M Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

10.  Isolation of Bacillus subtilis genes from a charon 4A library.

Authors:  E Ferrari; D J Henner; J A Hoch
Journal:  J Bacteriol       Date:  1981-04       Impact factor: 3.490

View more
  1 in total

1.  Secretory expression in Escherichia coli and Bacillus subtilis of human interferon alpha genes directed by staphylokinase signals.

Authors:  R Breitling; D Gerlach; M Hartmann; D Behnke
Journal:  Mol Gen Genet       Date:  1989-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.